fluanxol mite 0,50 mg filmovertrukne tabletter
h. lundbeck a/s - flupentixoldihydrochlorid - filmovertrukne tabletter - 0,50 mg
fluanxol mite 1 mg filmovertrukne tabletter
h. lundbeck a/s - flupentixoldihydrochlorid - filmovertrukne tabletter - 1 mg
fluanxol 1 mg filmovertrukne tabletter
2care4 aps - flupentixoldihydrochlorid - filmovertrukne tabletter - 1 mg
fluanxol 5 mg filmovertrukne tabletter
h. lundbeck a/s - flupentixoldihydrochlorid - filmovertrukne tabletter - 5 mg
fluanxol 5 mg overtrukne tabletter
h. lundbeck a/s - flupentixoldihydrochlorid - overtrukne tabletter - 5 mg
fluanxol depot 100 mg/ml injektionsvæske
h. lundbeck a/s - flupentixoldecanoat - injektionsvæske - 100 mg/ml
fluanxol depot 20 mg/ml injektionsvæske
h. lundbeck a/s - flupentixoldecanoat - injektionsvæske - 20 mg/ml
fluanxol mite 0,50 mg overtrukne tabletter
h. lundbeck a/s - flupentixoldihydrochlorid - overtrukne tabletter - 0,50 mg
fluanxol mite 1 mg overtrukne tabletter
h. lundbeck a/s - flupentixoldihydrochlorid - overtrukne tabletter - 1 mg
ceplene
laboratoires delbert - histamin dihydrochlorid - leukæmi, myeloid, akut - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). effekten af ceplene er ikke fuldt ud demonstreret hos patienter ældre end 60 år.